These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

713 related items for PubMed ID: 25456393

  • 1. Lymph node metastases of melanoma: challenges for BRAF mutation detection.
    Chen G, Dudley J, Tseng LH, Smith K, Gurda GT, Gocke CD, Eshleman JR, Lin MT.
    Hum Pathol; 2015 Jan; 46(1):113-9. PubMed ID: 25456393
    [Abstract] [Full Text] [Related]

  • 2. Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma.
    Siroy AE, Aung PP, Torres-Cabala CA, Tetzlaff MT, Nagarajan P, Milton DR, Curry JL, Ivan D, Prieto VG.
    Hum Pathol; 2017 Jan; 59():48-54. PubMed ID: 27666765
    [Abstract] [Full Text] [Related]

  • 3. Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.
    Long GV, Menzies AM, Nagrial AM, Haydu LE, Hamilton AL, Mann GJ, Hughes TM, Thompson JF, Scolyer RA, Kefford RF.
    J Clin Oncol; 2011 Apr 01; 29(10):1239-46. PubMed ID: 21343559
    [Abstract] [Full Text] [Related]

  • 4. BRAF mutation screening in melanoma: is sentinel lymph node reliable?
    Nardin C, Puzenat E, Prétet JL, Algros MP, Doussot A, Puyraveau M, Mougin C, Aubin F.
    Melanoma Res; 2015 Aug 01; 25(4):328-34. PubMed ID: 26020488
    [Abstract] [Full Text] [Related]

  • 5. BRAF V600E mutation and p27 kip1 expression in papillary carcinomas of the thyroid <or=1 cm and their paired lymph node metastases.
    Rodolico V, Cabibi D, Pizzolanti G, Richiusa P, Gebbia N, Martorana A, Russo A, Amato MC, Galluzzo A, Giordano C.
    Cancer; 2007 Sep 15; 110(6):1218-26. PubMed ID: 17685465
    [Abstract] [Full Text] [Related]

  • 6. Allele frequencies of BRAFV600 mutations in primary melanomas and matched metastases and their relevance for BRAF inhibitor therapy in metastatic melanoma.
    Satzger I, Marks L, Kerick M, Klages S, Berking C, Herbst R, Völker B, Schacht V, Timmermann B, Gutzmer R.
    Oncotarget; 2015 Nov 10; 6(35):37895-905. PubMed ID: 26498143
    [Abstract] [Full Text] [Related]

  • 7. BRAF-V600 Mutation Heterogeneity in Primary and Metastatic Melanoma: A Study With Pyrosequencing and Immunohistochemistry.
    Yaman B, Kandiloğlu G, Akalin T.
    Am J Dermatopathol; 2016 Feb 10; 38(2):113-20. PubMed ID: 26630683
    [Abstract] [Full Text] [Related]

  • 8. BRAF mutation-positive folliculotropic metastatic melanoma.
    Brick KE, Halling KC, Khan YK, Peters MS.
    Am J Dermatopathol; 2013 Jul 10; 35(5):609-12. PubMed ID: 23715079
    [Abstract] [Full Text] [Related]

  • 9. Tumor cellularity as a quality assurance measure for accurate clinical detection of BRAF mutations in melanoma.
    Dudley JC, Gurda GT, Tseng LH, Anderson DA, Chen G, Taube JM, Gocke CD, Eshleman JR, Lin MT.
    Mol Diagn Ther; 2014 Aug 10; 18(4):409-18. PubMed ID: 24604154
    [Abstract] [Full Text] [Related]

  • 10. Comparison between two widely used laboratory methods in BRAF V600 mutation detection in a large cohort of clinical samples of cutaneous melanoma metastases to the lymph nodes.
    Jurkowska M, Gos A, Ptaszyński K, Michej W, Tysarowski A, Zub R, Siedlecki JA, Rutkowski P.
    Int J Clin Exp Pathol; 2015 Aug 10; 8(7):8487-93. PubMed ID: 26339422
    [Abstract] [Full Text] [Related]

  • 11. Benign nodal nevi frequently harbor the activating V600E BRAF mutation.
    Taube JM, Begum S, Shi C, Eshleman JR, Westra WH.
    Am J Surg Pathol; 2009 Apr 10; 33(4):568-71. PubMed ID: 19033861
    [Abstract] [Full Text] [Related]

  • 12. MAP kinase activity supported by BRAF (V600E) mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastases.
    Birner P, Berghoff AS, Dinhof C, Pirker C, Capper D, Schoppmann SF, Petzelbauer P, von Deimling A, Berger W, Preusser M.
    Arch Dermatol Res; 2014 Dec 10; 306(10):873-84. PubMed ID: 25073704
    [Abstract] [Full Text] [Related]

  • 13. Accurate detection of BRAF p.V600E mutations in challenging melanoma specimens requires stringent immunohistochemistry scoring criteria or sensitive molecular assays.
    Fisher KE, Cohen C, Siddiqui MT, Palma JF, Lipford EH, Longshore JW.
    Hum Pathol; 2014 Nov 10; 45(11):2281-93. PubMed ID: 25228337
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.
    Long GV, Wilmott JS, Capper D, Preusser M, Zhang YE, Thompson JF, Kefford RF, von Deimling A, Scolyer RA.
    Am J Surg Pathol; 2013 Jan 10; 37(1):61-5. PubMed ID: 23026937
    [Abstract] [Full Text] [Related]

  • 15. Multisite analytic performance studies of a real-time polymerase chain reaction assay for the detection of BRAF V600E mutations in formalin-fixed, paraffin-embedded tissue specimens of malignant melanoma.
    Anderson S, Bloom KJ, Vallera DU, Rueschoff J, Meldrum C, Schilling R, Kovach B, Lee JR, Ochoa P, Langland R, Halait H, Lawrence HJ, Dugan MC.
    Arch Pathol Lab Med; 2012 Nov 10; 136(11):1385-91. PubMed ID: 22332713
    [Abstract] [Full Text] [Related]

  • 16. Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanoma.
    Pisareva E, Gutkina N, Kovalenko S, Kuehnapfel S, Hartmann A, Heinzerling L, Schneider-Stock R, Lyubchenko L, Shamanin VA.
    Melanoma Res; 2014 Aug 10; 24(4):322-31. PubMed ID: 24922189
    [Abstract] [Full Text] [Related]

  • 17. Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma.
    Menzies AM, Haydu LE, Visintin L, Carlino MS, Howle JR, Thompson JF, Kefford RF, Scolyer RA, Long GV.
    Clin Cancer Res; 2012 Jun 15; 18(12):3242-9. PubMed ID: 22535154
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of BRAF(V⁶⁰⁰) mutations in melanoma patients after resection of metastatic lymph nodes.
    Moreau S, Saiag P, Aegerter P, Bosset D, Longvert C, Hélias-Rodzewicz Z, Marin C, Peschaud F, Chagnon S, Zimmermann U, Clerici T, Emile JF.
    Ann Surg Oncol; 2012 Dec 15; 19(13):4314-21. PubMed ID: 22772867
    [Abstract] [Full Text] [Related]

  • 19. Spectrum and Frequency of BRAF Mutations in Skin Melanomas in the Dalmatian Region of Croatia.
    Bezić J, Tomić I, Pavić M.
    Acta Dermatovenerol Croat; 2024 Mar 15; 32(1):75-76. PubMed ID: 38946192
    [Abstract] [Full Text] [Related]

  • 20. A Retrospective Review of Conjunctival Melanoma Presentation, Treatment, and Outcome and an Investigation of Features Associated With BRAF Mutations.
    Larsen AC, Dahmcke CM, Dahl C, Siersma VD, Toft PB, Coupland SE, Prause JU, Guldberg P, Heegaard S.
    JAMA Ophthalmol; 2015 Nov 15; 133(11):1295-303. PubMed ID: 26425792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.